{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:27:42Z","timestamp":1773340062707,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.vaccine.2009.06.105","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T13:38:44Z","timestamp":1248529124000},"page":"5496-5504","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE\u00ae against aerosolized rabbitpox virus in a rabbit model"],"prefix":"10.1016","volume":"27","author":[{"given":"Nicole L.","family":"Garza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh M.","family":"Hatkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald K.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Nalca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.06.105_bib1","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3181\/00379727-30-6724","article-title":"A pandemic of rabbit-pox","volume":"30","author":"Greene","year":"1933","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2009.06.105_bib2","series-title":"Virus infections of rodents and lagomorphs","first-page":"51","article-title":"Rabbitpox virus","author":"Fenner","year":"1994"},{"key":"10.1016\/j.vaccine.2009.06.105_bib3","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1128\/JVI.00423-07","article-title":"Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox","volume":"81","author":"Adams","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2009.06.105_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/323897","article-title":"Countering the posteradication threat of smallpox and polio","volume":"34","author":"Henderson","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.06.105_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung, eigenschaften und verwendung des attenuierten vaccinia-stammes MVA (passage history, properties, and applicability of the attenuated vaccinia virus strain MVA)","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2009.06.105_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib8","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.83156-0","article-title":"Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara","volume":"88","author":"Meisinger-Henschel","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA\u2014stufenimpfung gegen pocken. Kleinische erprobung des attenuierten pocken-lebendimpfstoffes, stamm MVA (MVA vaccination against smallpox:clinical tests with an attenuated live vaccinia virus strain (MVA))","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch Med Wschr"},{"key":"10.1016\/j.vaccine.2009.06.105_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.06.105_bib11","first-page":"407","article-title":"IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection","volume":"10","author":"Jones","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2009.06.105_bib12","unstructured":"21 CFR Parts 314 and 601. New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible; 2002. Food and Drug Administration, HHS."},{"key":"10.1016\/j.vaccine.2009.06.105_bib13","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.105_bib14","series-title":"Biodefense: research methodology and animal models","first-page":"61","article-title":"Infectious disease aerobiology: aerosol challenge methods","author":"Roy","year":"2006"},{"key":"10.1016\/j.vaccine.2009.06.105_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","article-title":"Smallpox and pan-orthopox virus detection by real-time 3\u2032-minor groove binder TaqMan assays on the Roche lightcycler and the Cepheid smart cycler platforms","volume":"42","author":"Kulesh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib16","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.105_bib17","first-page":"1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"1803","author":"Bray","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2009.06.105_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/513968","article-title":"Immunologic responses to vaccinia vaccines administrated by different parenteral routes","volume":"175","author":"McClain","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.06.105_bib19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2009.06.105_bib20","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib21","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax\u00ae challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.105_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus Ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.06.105_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.06.105_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.06.105_bib25","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"March (101)","author":"Wyatt","year":"2004","journal-title":"PNAS"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09009876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09009876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T05:57:08Z","timestamp":1545112628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09009876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":25,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0264410X09009876"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}